tiprankstipranks
Trending News
More News >
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF
US Market

Chugai Pharmaceutical Co (CHGCF) Ratios

Compare
18 Followers

Chugai Pharmaceutical Co Ratios

CHGCF's free cash flow for Q4 2024 was ¥0.69. For the 2024 fiscal year, CHGCF's free cash flow was decreased by ¥ and operating cash flow was ¥0.41. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.53 4.74 3.15 3.25 3.54
Quick Ratio
4.70 3.79 2.46 2.61 2.76
Cash Ratio
1.86 1.59 0.52 0.82 0.90
Solvency Ratio
1.35 1.16 0.91 0.95 0.96
Operating Cash Flow Ratio
1.54 1.42 0.58 0.85 0.87
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 1.30T¥ 1.06T¥ 891.17B¥ 712.98B¥ 579.41B
Leverage Ratios
Debt-to-Assets Ratio
0.00 <0.01 <0.01 0.01 <0.01
Debt-to-Equity Ratio
0.00 <0.01 <0.01 0.01 0.01
Debt-to-Capital Ratio
0.00 <0.01 <0.01 0.01 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.16 1.19 1.31 1.30 1.26
Debt Service Coverage Ratio
-401.82 0.00 6.65K 6.96K 3.96K
Interest Coverage Ratio
-527.75 0.00 8.74K 8.79K 4.86K
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
-0.62 8.18 8.62 9.78 6.90
Net Debt to EBITDA
-0.95 -0.94 -0.37 -0.56 -0.61
Profitability Margins
Gross Profit Margin
71.01%62.81%62.20%66.18%65.25%
EBIT Margin
46.30%39.94%42.33%41.95%37.90%
EBITDA Margin
48.55%42.80%44.66%45.04%41.77%
Operating Profit Margin
46.30%39.52%42.33%42.20%38.28%
Pretax Profit Margin
46.39%39.93%42.16%41.95%37.89%
Net Profit Margin
33.09%29.29%29.72%30.31%27.29%
Continuous Operations Profit Margin
33.09%29.29%29.72%30.31%27.29%
Net Income Per EBT
71.32%73.33%70.49%72.25%72.01%
EBT Per EBIT
100.19%101.06%99.60%99.40%98.99%
Return on Assets (ROA)
17.54%16.84%20.03%19.69%17.38%
Return on Equity (ROE)
20.37%20.02%26.29%25.50%21.91%
Return on Capital Employed (ROCE)
28.26%26.71%36.88%34.83%30.14%
Return on Invested Capital (ROIC)
20.16%19.59%26.00%25.16%21.70%
Return on Tangible Assets
17.68%17.02%20.30%19.98%17.72%
Earnings Yield
3.36%3.70%6.76%4.93%2.37%
Efficiency Ratios
Receivables Turnover
3.50 3.49 2.46 2.81 3.11
Payables Turnover
5.19 7.62 2.27 2.22 2.72
Inventory Turnover
1.41 1.51 1.63 1.62 1.49
Fixed Asset Turnover
2.65 2.64 3.26 2.84 2.65
Asset Turnover
0.53 0.58 0.67 0.65 0.64
Working Capital Turnover Ratio
0.98 1.12 1.53 1.50 1.41
Cash Conversion Cycle
292.11 298.35 211.61 191.04 228.96
Days of Sales Outstanding
104.22 104.73 148.48 129.97 117.51
Days of Inventory Outstanding
258.17 241.52 223.95 225.42 245.45
Days of Payables Outstanding
70.28 47.90 160.82 164.36 134.00
Operating Cycle
362.39 346.25 372.43 355.40 362.96
Cash Flow Ratios
Operating Cash Flow Per Share
272.02 249.16 148.41 170.07 124.76
Free Cash Flow Per Share
241.07 204.03 105.10 125.75 87.39
CapEx Per Share
30.95 45.14 43.31 44.32 37.37
Free Cash Flow to Operating Cash Flow
0.89 0.82 0.71 0.74 0.70
Dividend Paid and CapEx Coverage Ratio
2.43 1.99 1.17 1.63 1.34
Capital Expenditure Coverage Ratio
8.79 5.52 3.43 3.84 3.34
Operating Cash Flow Coverage Ratio
0.00 30.47 17.30 17.43 18.17
Operating Cash Flow to Sales Ratio
0.38 0.37 0.19 0.28 0.26
Free Cash Flow Yield
3.44%3.82%3.12%3.37%1.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
29.73 27.00 14.80 20.27 42.12
Price-to-Sales (P/S) Ratio
9.84 7.91 4.40 6.14 11.49
Price-to-Book (P/B) Ratio
6.06 5.41 3.89 5.17 9.23
Price-to-Free Cash Flow (P/FCF) Ratio
29.03 26.18 32.04 29.70 62.97
Price-to-Operating Cash Flow Ratio
25.73 21.44 22.69 21.96 44.11
Price-to-Earnings Growth (PEG) Ratio
1.57 -2.06 0.63 0.49 1.16
Price-to-Fair Value
6.06 5.41 3.89 5.17 9.23
Enterprise Value Multiple
19.31 17.54 9.48 13.08 26.90
EV to EBITDA
19.31 17.54 9.48 13.08 26.90
EV to Sales
9.38 7.51 4.23 5.89 11.24
EV to Free Cash Flow
27.67 24.86 30.84 28.48 61.57
EV to Operating Cash Flow
24.52 20.35 21.84 21.06 43.13
Tangible Book Value Per Share
1.14K 976.00 850.71 709.21 581.78
Shareholders’ Equity Per Share
1.16K 988.07 866.00 722.57 596.31
Tax and Other Ratios
Effective Tax Rate
0.29 0.27 0.30 0.28 0.28
Revenue Per Share
711.42 675.52 766.02 608.07 478.84
Net Income Per Share
235.39 197.83 227.64 184.29 130.66
Tax Burden
0.71 0.73 0.70 0.72 0.72
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.15 0.16 0.12 0.14 0.15
SG&A to Revenue
0.00 0.00 0.02 0.03 0.03
Stock-Based Compensation to Revenue
<0.01 0.00 0.00 0.00 0.00
Income Quality
1.16 1.26 0.42 0.59 0.60
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis